[ad_1]
ANAHEIM, Calif., August 4, 2019 / PRNewswire / – At the 71st The annual AACC scientific conference and clinical laboratory, experts in laboratory medicine will present cutting-edge research and technology that is revolutionizing clinical trials and patient care. Of August 4-8 in Anaheim, California, the more than 200 meetings of the meeting will provide information on a wide range of current health care topics. Among the highlights of these discussions are discussions exploring genetic testing directly with consumers, advances in precision medicine to date, how genes shape the brain circuits that define human behavior, and emerging technologies ranging from novel drug tests. cannabis with extremely fast molecular diagnosis.
Direct genetic test to the consumer. The popularity of genetic testing for the consumer is increasing exponentially, with as many people purchasing these tests in 2018 as all previous years combined. A special session will highlight the misunderstood nuances of consumer genetic testing, focusing on how health professionals can enable patients to benefit from these tests while raising public awareness of their limitations. .
Precision medicine. Precision medicine consists of adapting treatments based on the results of genetic and other tests to determine which interventions patients will respond best. In theory, this approach could revolutionize health care, but in practice, the medical community has struggled to implement it in a widespread way. David R. Walt, PhD, of Harvard Medical School, will kick off the meeting with a keynote address on how to address one of the biggest challenges to precision medicine: the difficulty of translating promising research discoveries into tests and treatments that have an impact on the health of patients. patients.
Virginia Kaklamani, MD, DSc, of the University of Texas Health The San Antonio MD Anderson Cancer Center will examine how precision medicine identifies bad cancer patients who will respond to targeted treatments, including those unlikely to respond to chemotherapy, which will help them avoid this toxic treatment.
Finally, Euan Ashley, MB ChB, DPhil, of the Stanford Center for Inherited Cardiovascular Disease, will highlight new genomic sequencing technologies that could advance precision medicine, while exploring the possible short-term uses of advanced medicine. precision – as the resolution of the mystery unidentifiable diseases.
The genetics of human behavior. In another plenary meeting, Julie Korenberg, MD, PhD, Center for Integrated Neurosciences and Human Behavior at the University of Utahwill explain how genetic mutations lead to changes in the brain circuits responsible for cognitive deficits. Understanding this could lead to drugs for developmental disorders such as Down syndrome and Williams syndrome, while clarifying the fundamentals of human behavior.
Emerging technology. It is essential to understand the effects of marijuana on driving performance now that many states have legalized the recreational and medical use of this drug. A last-minute session will focus on the contribution of mbad spectrometry to the development of this issue, as well as other groundbreaking applications of this emerging diagnostic technology.
In the keynote address of the meeting, Carl Wittwer, MD, PhD, of University of Utah, will explore extremely fast molecular diagnostics that will provide answers in seconds that could allow immediate diagnosis and treatment for a wide range of conditions.
In addition, at the Clinical Lab Expo, more than 800 exhibitors will present innovative technologies that have just been commercialized in all disciplines of clinical laboratories.
"The ability of laboratory medicine to improve quality of life is constantly increasing, and advanced diagnostic technologies are emerging every day in areas as diverse as cancer, neurology, genomics and drug testing", said the general manager of the AACC. Janet B. Kreizman. "The 71st The annual AACC scientific meeting will highlight the pioneers of laboratory medicine who are mobilizing these innovations to improve patient care. "
Session Information
Registration at the annual scientific meeting of the AACC is free for members of the media. Journalists can register online here: https://www.xpressreg.net/register/aacc0819/media/landing.asp
Direct genetic testing for consumption
Session 11002: Consumer Genomics, Direct Consumption Genetic Testing and Patient Empowerment
Sunday August 4th
15:30 – 16.30.
Piece 204B
Precision medicine
Session 11001: Biomarker Discovery: From Technological Development to Clinical Applications
Sunday August 4th
5 – 18.30.
ABC of the ballroom
Session 13001: Using Biomarkers to Customize Breast Cancer Treatment
Tuesday August 6th
8:45 am – 10:15
ABC of the ballroom
Session 14001: Towards a Precision Medicine
Wednesday August 7th
8:45 am – 10:15
ABC of the ballroom
Genetics of human behavior
Session 12001: Translating Genes, Brain and Behavior: A Next Generation Human Framework
Monday August 5th
8:45 am – 10:15
ABC of the ballroom
Emerging technology
Session 32224: Marijuana, Metabolomics and Multiplex Imaging – Late-Stage Applications of Mbad Spectrometry
Monday August 5th
2:15 – 4:15 p.m.
Room 204A
Session 15001: Extreme Molecular Diagnostics
Thursday, August 8
8:45 am – 10:15
ABC of the ballroom
All sessions will take place at Anaheim Congress Center in Anaheim, California.
On the 71st Annual Scientific Congress and Clinical Laboratory Salon of the AACC
The AACC annual scientific meeting offers 5 days filled with opportunities to learn the exciting sciences of August 4-8. The plenary sessions present the latest research on accelerating the clinical adoption of new biomedical discoveries, the influence of genetics and brain circuits on behavior, targeted treatment of bad cancer, advances in precision medicine and extremely fast molecular diagnostic tests.
At the AACC Clinical Lab Expo, more than 800 exhibitors will invade the exhibition hall of the show Anaheim Congress Center in California with displays of the latest diagnostic technology, including, but not limited to, mobile health, molecular diagnostics, mbad spectrometry, point of service and automation.
About the AACC
Dedicated to improving health through laboratory medicine, the AACC brings together more than 50,000 clinical laboratory professionals, physicians, researchers and business leaders from around the world specializing in clinical chemistry, molecular diagnostics, mbad spectrometry, translational medicine, laboratory management and others. areas of laboratory science in progress. Since 1948, AACC has worked to advance the sector's common interests by delivering programs that foster scientific collaboration, knowledge, expertise and innovation. For more information, visit www.aacc.org.
Christine DeLong
AACC
Senior Manager, Communications and Public Relations
(p) 202.835.8722
[email protected]
Molly Polen
AACC
Senior Director, Communications and Public Relations
(p) 202.420.7612
(c) 703.598.0472
[email protected]
SOURCE AACC
Related Links
http://www.aacc.org
Source link
